Currently, inhibition of tumor angiogenesis has been shown to be a promising therapeutic strategy in cancer treatment, and Vascular-Endothelial Growth Factor (VEGF) inhibitory drugs have been used successfully in clinical practice [12]. This evidence concerns the gene VEGFA and cancer.